PREPRINT (not peer reviewed)

A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PsyArXiv
Date: 2022-07-01
Source: PsyArXiv
DOI: 10.31234/osf.io/sb5ur
PubMed: Unavailable

Authors

Nayak SM Bari BA Yaden DB Spriggs MJ Rosas F Peill JM Giribaldi B Erritzoe D Nutt D Carhart-Harris R.

Watch author

Derived topics and classifications

psilocybin Depression Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.Psychiatry research · 2026-05-01 Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-16 Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.JAMA psychiatry · 2024-12-01 Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05 Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.Journal of psychopharmacology (Oxford, England) · 2023-07-01 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01 Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01 Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-28